Cargando…
mTOR Signal Transduction Pathways Contribute to TN-C FNIII A1 Overexpression by Mechanical Stress in Osteosarcoma Cells
Osteosarcoma is the most common primary malignant bone tumor with a very poor prognosis. Treating osteosarcoma remains a challenge due to its high transitivity. Tenascin-C, with large molecular weight variants including different combinations of its alternative spliced FNIII repeats, is specifically...
Autores principales: | Zheng, Lianhe, Zhang, Dianzhong, Zhang, Yunfei, Wen, Yanhua, Wang, Yucai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Society for Molecular and Cellular Biology
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935624/ https://www.ncbi.nlm.nih.gov/pubmed/24598996 http://dx.doi.org/10.14348/molcells.2014.2247 |
Ejemplares similares
-
mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016) -
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
por: Glaviano, Antonino, et al.
Publicado: (2023) -
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012) -
EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling
por: Cheng, Dong-dong, et al.
Publicado: (2018) -
Overexpression of mTOR in Leukocytes from ALS8 Patients
por: Gomes, Nathália Augusta, et al.
Publicado: (2023)